ADAP   $0.66  3.13% Market Closed After Close 0.66 0.0

Adaptimmune Therapeutics PLC
Total Cash 214.79M
totalCashPerShare 0.14
EBITDA -72.88M
Total Debt 47.35M
quickRatio 2.907
currentRatio 3.092
Total Revenue 141.46M
debtToEquity 49.18
Revenue/Share 0.595
ROA -0.15837
ROE -0.65044
grossProfits
freeCashflow -7.95M
operatingCashflow -44.39M
earningsGrowth
revenueGrowth 23.996
grossMargins -0.0367
ebitdaMargins -0.5152
operatingMargins 0.53575003
profitMargins -0.51252
enterpriseValue 1.11B
forwardPE -2.241579
floatShares 1.02B
sharesOutstanding 255.74M
sharesShort 5.56M
sharesShortPriorMonth 7.00M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.62%
Short Ratio help_outline 5.00%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 0.377
Price To Book help_outline 2.26
earningsQuarterlyGrowth
netIncomeToCommon -72.50M
trailingEps -0.36%
forwardEps -0.38%
enterpriseToEbitda -15.18
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.13 3Q 2024
institutionsCount 95
lastUpdated Nov. 6, 2024, 6:30 p.m.